Poslední zkoušky

EudraCT Number: 2004-000185-12

Sponsor Protocol Number: CELC200A2401 / 2939107

Start Date: 2004-09-21

Sponsor Name: Orion Corporation, ORION PHARMA

Full Title: A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center study to evaluate the effect of Stalevo® in patients with Parkinson’s disease requiring initiation...

Medical condition: Parkinson's disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10061536		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) SE (Completed) AT (Completed) GB (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-002249-11

Sponsor Protocol Number: BLQ-01-003-04

Start Date: 2004-09-20

Sponsor Name: BAUSCH&LOMB - IOM S.P.A.

Full Title: Double blind, randomized, multicenter, placebo-controlled, parallel-group design clinical trial of the efficacy and tolerability of cloriclomene hydrochloride capsules 100 mg TID in diabetic patien...

Medical condition: Mild to moderate non-proliferative diabetic retinopathy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2004-001600-12

Sponsor Protocol Number: F/2004/2.

Start Date: 2004-09-20

Sponsor Name: OMNINVEST Kft.

Full Title: Fluval AB Vaccine Serologic Clinical Trial

Medical condition: Immunization of healthy people against influenza virus infections.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed)

Trial results: View results

EudraCT Number: 2004-000838-36

Sponsor Protocol Number: PX104.1.7-201

Start Date: 2004-09-20

Sponsor Name: Pharmexa A/S

Full Title: A Phase II trial evaluating the immunological and clinical efficay and safety of HER-2 Protein Autovac(TM) monotherapy in patients with metastatic breast cancer

Medical condition: Female patients with histologically proven metastatic or locally advanced breast cancer who have HER-2 overexpression in the primary tumour and/or a metastatic lesion.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: HU (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000083-27

Sponsor Protocol Number: GT-08

Start Date: 2004-09-19

Sponsor Name: ALK-Abelló A/S

Full Title: A randomised, parallel-group, double-blind, placebo-controlled Phase III trial assessing the efficacy and safety of ALK Grass Tablet Phleum pratense in subjects with seasonal grass pollen induced r...

Medical condition: Rhinoconjunctivitis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: SE (Completed) IT (Completed) ES (Completed) AT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2004-000091-14

Sponsor Protocol Number: FFR102123

Start Date: 2004-09-17

Sponsor Name: GlaxoSmithKline, S.A

Full Title: A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre, Long-Term Study to Evaluate the Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg ...

Medical condition: Perennial allergic rhinitis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) SE (Completed) LV (Completed) LT (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-002137-39

Sponsor Protocol Number: V1 25/07/04

Start Date: 2004-09-17

Sponsor Name:

Full Title: A randomised controlled trial of the combined use of paracetamol and ibuprofen to treat febrile children

Medical condition: Fevers in childhood not asscoaited with severe disease in the immunocompenetent or fever in the immunocompromised host.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2004-001347-29

Sponsor Protocol Number:

Start Date: 2004-09-17

Sponsor Name: Odense University Hospital

Full Title: Treatment of patients with locally advanced rectal cancer. TEGAFOX (UFT/leukovorin og Oxaliplatin) before, during and after curatively intended radiotherapy. A Danish phase I/II trial

Medical condition: Locally advanced non-resectable rectal cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.0		10038050		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: View results

EudraCT Number: 2005-003701-91

Sponsor Protocol Number: INT 27/04

Start Date: 2004-09-17

Sponsor Name: ISTITUTO NAZIONALE PER LA CURA TUMORI

Full Title: ONCE WEEKLY DOSING OF DARBEPOETIN ALPHA AS PROPHYLACTIC TREATMENT FOR ANEMIA IN ELDERLY CANCER PATIENTS

Medical condition: ELDERLY PATIENTS WITH GASTROINTESTINAL AND LUNG CANCER

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10029104		SOC

Population Age: Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-000850-22

Sponsor Protocol Number: 044(2A)SC04030

Start Date: 2004-09-17

Sponsor Name: ANGELINI

Full Title: Evaluation of tolerability and analgesic activity of paracetamol 1000 mg+caffeine 130 mg in the treatment of tension-type headache. Randomized, double blind, double-dummy, cross-over study vs. napr...

Medical condition: Evaluation of tolerability and analgesic activity in the treatment of tension-type headache

Disease:	Version	SOC Term	Classification Code	Term	Level
			10043269		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

Poslední zkoušky

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence